Source:http://linkedlifedata.com/resource/pubmed/id/12242146
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-9-20
|
pubmed:abstractText |
A little more than one year after the first demonstration that silencing of endogenous human genes is possible in cell culture, the new tool of RNA interference (RNAi) enters the field of tumor therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1535-6108
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
167-8
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading | |
pubmed:year |
2002
|
pubmed:articleTitle |
Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment?
|
pubmed:affiliation |
Children's University Hospital Giessen, Pediatric Hematology and Oncology, Feulgenstr. 12, 35392, Giessen, Germany. arndt.borkhardt@paediat.med.uni-giessen.de
|
pubmed:publicationType |
Journal Article,
Review
|